MAXLINEAR, INC. |
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS |
(in thousands, except per share data) |
|
|
Six Months Ended |
|
June 30, 2018 | |
June 30, 2017 |
Net revenue | $ | 212,360 | | | $ | 193,016 | |
Cost of net revenue | 93,362 | | | 88,988 | |
Gross profit | 118,998 | | | 104,028 | |
Operating expenses: | | | |
Research and development | 61,332 | | | 52,893 | |
Selling, general and administrative | 51,618 | | | 49,951 | |
Restructuring charges | 1,865 | | | 6,546 | |
Total operating expenses | 114,815 | | | 109,390 | |
Income (loss) from operations | 4,183 | | | (5,362 | ) |
Interest income | 37 | | | 259 | |
Interest expense | (7,588 | ) | | (2,201 | ) |
Other income (expense), net | 154 | | | (762 | ) |
Total interest and other income (expense), net | (7,397 | ) | | (2,704 | ) |
Loss before income taxes | (3,214 | ) | | (8,066 | ) |
Income tax provision (benefit) | 9,361 | | | (27,494 | ) |
Net income (loss) | $ | (12,575 | ) | | $ | 19,428 | |
Net income (loss) per share: | | | |
Basic | $ | (0.18 | ) | | $ | 0.30 | |
Diluted | $ | (0.18 | ) | | $ | 0.28 | |
Shares used to compute net income (loss) per share: | | | |
Basic | 68,008 | | | 65,564 | |
Diluted | 68,008 | | | 69,398 | |
MAXLINEAR, INC. |
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS |
(in thousands) |
|
|
Three Months Ended |
|
June 30, 2018 | |
March 31, 2018 | |
June 30, 2017 |
Operating Activities | | | | | |
Net income (loss) | $ | (14,422 | ) | | $ | 1,847 | | | $ | 10,965 | |
Adjustments to reconcile net income (loss) to cash provided by operating activities | | | | | |
Amortization and depreciation | 20,051 | | | 20,084 | | | 18,261 | |
Accretion of investment discount | | | | | | | (107 | ) |
Amortization of inventory step-up | | | | | | | 5,635 | |
Amortization of debt issuance costs and discount | 287 | | | 287 | | | 175 | |
Stock-based compensation | 7,309 | | | 8,473 | | | 11,628 | |
Deferred income taxes | (1,289 | ) | | (2,332 | ) | | (53,297 | ) |
Loss on disposal of property and equipment | | | | | | | 3 | |
Loss on sale of available-for-sale securities | | | | | | | 38 | |
(Gain) loss on foreign currency | (828 | ) | | 471 | | | 898 | |
Excess tax benefits on stock-based awards | (318 | ) | | (797 | ) | | (2,376 | ) |
Impairment of leasehold improvements | 700 | | | | | | | |
Changes in operating assets and liabilities: | | | | | |
Accounts receivable | 6,979 | | | (24,533 | ) | | (13,496 | ) |
Inventory | 1,420 | | | 7,676 | | | (2,289 | ) |
Prepaid expenses and other assets | 2,213 | | | 1,003 | | | 4,385 | |
Accounts payable, accrued expenses and other current liabilities | 11,540 | | | (421 | ) | | 7,610 | |
Accrued compensation | 1,401 | | | 2,502 | | | (1,664 | ) |
Deferred revenue and deferred profit | | | | (138 | ) | | 7,633 | |
Accrued price protection liability | (132 | ) | | (1,359 | ) | | 2,676 | |
Other long-term liabilities | 913 | | | (792 | ) | | (3,768 | ) |
Net cash provided by (used in) operating activities | 35,824 | | | 11,971 | | | (7,090 | ) |
| | | | | |
Investing Activities | | | | | |
Purchases of property and equipment | (2,423 | ) | | (2,381 | ) | | (1,155 | ) |
Purchases of intangible assets | | | | | | | (5,205 | ) |
Cash used in acquisition, net of cash acquired | | | | | | | (473,304 | ) |
Maturities of available-for-sale securities | | | | | | | 63,761 | |
Net cash used in investing activities | (2,423 | ) | | (2,381 | ) | | (415,903 | ) |
| | | | | |
Financing Activities | | | | | |
Net proceeds from issuance of debt | | | | | | | 416,846 | |
Repayment of debt | (18,000 | ) | | (25,000 | ) | | | |
Net proceeds from issuance of common stock | 3,036 | | | 980 | | | 7,657 | |
Minimum tax withholding paid on behalf of employees for restricted stock units | (1,448 | ) | | (2,391 | ) | | (3,496 | ) |
Net cash provided by (used in) financing activities | (16,412 | ) | | (26,411 | ) | | 421,007 | |
Effect of exchange rate changes on cash and cash equivalents | 793 | | | (258 | ) | | 839 | |
Increase (decrease) in cash, cash equivalents and restricted cash | 17,782 | | | (17,079 | ) | | (1,147 | ) |
Cash, cash equivalents and restricted cash at beginning of period | 57,333 | | | 74,412 | | | 91,238 | |
Cash, cash equivalents and restricted cash at end of period | $ | 75,115 | | | $ | 57,333 | | | $ | 90,091 | |